Disclosure: Voyageur Pharmaceuticals Ltd. has paid FRC a fee for research coverage and distribution of reports. This fee creates a potential conflict of interest which readers should consider. See last page for other important disclosures, rating, and risk definitions.
.webp&w=128&q=75)
.webp&w=128&q=75)
Discussion
Comments reflect the views of individual users, not FRC. Nothing posted in the comments section — by users or otherwise — should be taken as investment advice.